M & A
Nemetschek: completion of portfolio
GTecDax listed Nemetschek AG is bidding to take over the Norwegian company Data Design System ASA for a sum in excess of 10 million Euros. The software group intends finalising the deal before the end of this year. With a staff of 90, the Norwegian company supplies CAD-based advanced Building Information Modelling for the design and documentation of electrical, HVAC and plumbing systems for buildings. Nemetschek, a supplier of CAD and software, will thus broaden its range of products for construction processes. Data Design System’s turnover for 2012 was 8.7 million Euros and EBIT of some 1.5 million Euros.
Delignit: environmentally worthwhile
Woodworking company Delignit AG takes over DHK automotive GmbH (interior finishings for cars) and all its holdings in HTZ Holztrocknung GmbH. The parties involved have agreed not to reveal the price of the deal. This acquisition of the two manufacturers of Saxony broadens the range of Delignit’s environmentally aware products and system solutions, and adds to its production capacity. DHK automotive is not restricted to coverings for luggage racks; it also supplies interior lateral finishings for industrial vehicles. Of particular importance and a worthwhile addition to Delignit’s product range is a special procedure for beehive construction materials in vegetable fibre, characterised by sustainability and lightness. For the first time, and for 2014, Delignit’s has set its sales target above 40 million Euros.
Eckert & Ziegler: Bridges towards the US market
After taking over Biocompatibles, Eckert & Ziegler Strahlen – and Medizintechnik AG has acquired the entire share quota of Mick Radio Nuclear Instruments, Inc. (MRNI). MRNI, manufactures accessories for the brachytherapy radioisotope treatment of tumours with a turnover for 2012 of 4 million Euros. Both parties have resolved to keep the price of the transaction under wraps. Eckert & Ziegler is hoping its investment in Biocompatibles, producer of implants used in the treatment of prostate cancer, will bolster its standing in the US market. The company confirms that brachytherapy is a highly efficient option in the treatment of a number of tumours. MRNI is deemed to be a market leader in the application of this form of therapy and has enormous drive towards innovation and possesses several patents. Eckert & Ziegler is listed in the Prime Standards.